Chemical Structure (Valtoco 01)
Valtoco Spray
Product Images NDC 72252-505
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Valtoco (NDC 72252-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Neurelis, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Valtoco 02)
This appears to be a graph or chart titled "Diazepam Rectal Gel Placebo". It shows the percentage of patients and has categories marked on the x-axis but the y-axis is not labeled. Without more context or information, it is not possible to give a more specific description of the graph's purpose or meaning.*
Figure 2 (Valtoco 03)
Figure 3 (Valtoco 04)
This text is a list of medical terms and does not provide enough context to generate a useful description.*
Figure (Valtoco 05)
Figure (Valtoco 06)
Figure (Valtoco 07)
Figure (Valtoco 08)
Figure (Valtoco 09)
Figure (Valtoco 10)
Figure (Valtoco 11)
Figure (Valtoco 12)
This text is essentially a single word "Nozzle" and does not require further explanation.*
Figure (Valtoco 13)
Figure (Valtoco 14)
Figure (Valtoco 15)
Principal Display Panel (5 mg Device Blister Pack Carton)
Valtoco is a nasal spray device containing 5mg of diazepam. The device sprays one time only and should not be opened or tested before use. Each box contains 2 blister packs, and each blister pack contains one nasal spray device. The recommended dose should be determined by a doctor, and the prescribing information and instructions for use can be found inside the box and blister packs. Valtoco should be stored at room temperature between 20°C and 25°C and should be kept out of reach of children. The box has important information for pharmacists, including the product's expiration date and its active and inactive ingredients. For more information about Valtoco, one can visit the website or call the provided number.*
Principal Display Panel (15 mg Device Blister Pack Carton)
Valtoco's nasal spray devices contain 15mg of diazepam each, intended for nasal use only. The box contains 2 blister packs, each with 2 nasal spray devices. One dose is administered per device for a total of 2 doses per box. It is not recommended to test nasal sprays or open blister packs before using them. The recommended storage temperature for Valtoco is between 20°C and 25°C, and it must be protected from light and kept out of reach of children. If the product is damaged, you may not receive the full dose. For more information and instructions for use, refer to the box and blister packs or visit www.valtoco.com.*
Principal Display Panel (10 mg Device Blister Pack Carton)
VALTOCO is a nasal spray device used to treat epilepsy. Each blister pack with two nasal spray devices contains 10 mg of diazepam. The device sprays one time only, and should not be opened or tested before use. The recommended dosage and precautions are specified in the prescribing information. The product should be inspected for damages before use, and kept between 20°C to 25°C. VALTOCO should be avoided by children and is to be dispensed as a unit by pharmacists. The medication guide enclosed with the box should be provided to the patient, as they provide information about how to use the device properly. The nasal spray contains benzyl alcohol, dehydrated alcohol, dodecyl beta-D-maltoside, and vitamin E. For more information on VALTOCO, go to www.valtoco.com or call 1-866-696-3873.*
Principal Display Panel (20 mg Device Blister Pack Carton)
VALTOCO (diazepam nasal spray) is a medication that is administered nasally using a device that sprays a one-time dose of 20 mg. The package contains two blister packs with two nasal spray devices, each containing 10 mg of diazepam in 0.1 mL solution. The medication should not be frozen, and the recommended storage temperature is between 20°C and 55°C (68°F and 77°F). It is important to check the product's expiration date before using it. For more information on VALTOCO nasal spray, visit the official website or call customer service.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
